NYSE
PBH
Last Price
US $47.19
KEY FIGURES
MKT CAP
$2.2B
EPS
TTM
$4.01
PEG
TTM
N/M
P/E
TTM
11.76x
P/S
TTM
2.06x
YIELD
0.00%
GROWTH
Revenue Y/Y
Valuation
Financial
Performance
Financial stability - Cash flow debt coverage.
Prestige Consumer Healthcare Inc. cash flow to debt ratio of 25.39% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.
Financial stability - Healthy cash flow growth.
Prestige Consumer Healthcare Inc.'s free cash flow has increased 4.50% from $243.29M last year to $254.23M, signaling increasing performance
Financial stability - Healthy debt to equity ratio.
Prestige Consumer Healthcare Inc.'s debt to equity ratio is 0.55, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.
Financial stability - Healthy debt to equity ratio development.
Prestige Consumer Healthcare Inc.'s debt has decreased relative to shareholder equity from 0.57 last year to 0.55 today, signaling strengthened financials
Financial stability - Net debt/EBITDA.
Prestige Consumer Healthcare Inc. has a net debt to EBITDA ratio of 2.96x, which is below the 3.00x threshold, indicating healthy leverage and financial stability
Financial stability - ICR.
Prestige Consumer Healthcare Inc.'s interest coverage ratio of 7.31 indicates that earnings with good margin can cover interest payments on company debt
Financial risk - Profit margin growth.
Prestige Consumer Healthcare Inc.'s profit margin has decreased (-7.33%) in the last year from 18.86% to 17.48%, signaling decreasing performance
Financial stability - Short term assets vs short term liabilities.
Prestige Consumer Healthcare Inc.'s short-term assets of $431.48M exceed its short-term liabilities of $120.92M
Increasing performance - ROA.
Prestige Consumer Healthcare Inc.'s return on assets of 5.36% is higher than the 5.00% threshold, indicating efficient asset utilization
Decreasing performance - Absolute return on equity.
Prestige Consumer Healthcare Inc.'s return on equity of 10.29%, is lower than 15.00%, indicating bad performance
Increasing performance - Earnings quality.
Prestige Consumer Healthcare Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Increasing performance - Earnings stability.
Prestige Consumer Healthcare Inc. had positive net income in 4.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
Prestige Consumer Healthcare Inc. has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
Prestige Consumer Healthcare Inc. has a free cash flow yield of 11.37%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Decreasing performance - Healthy earnings growth.
Prestige Consumer Healthcare Inc.'s yearly earnings has decreased -11.32% since last year from $214.60M to $190.30M, signaling decreasing performance
Decreasing performance - Healthy revenue growth.
Prestige Consumer Healthcare Inc.'s yearly revenue has decreased -4.31% since last year from $1.14G to $1.09G, signaling decreasing performance
Increasing performance - ROIC.
ROIC 6.65% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.
Decreasing performance - 3-year revenue CAGR.
Prestige Consumer Healthcare Inc.'s 3-year revenue CAGR of -1.17% is negative, indicating declining revenue over the past 3 years
Increasing performance - Revenue consistency.
Prestige Consumer Healthcare Inc. had revenue growth in 3.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
Prestige Consumer Healthcare Inc. had positive ROE in 4.00 out of 5 years, indicating consistent and reliable returns on equity
Undervalued - DCF valuation.
Prestige Consumer Healthcare Inc. is undervalued relative to its fair value price of 49.72 based on Discounted Cash Flow model
Undervalued - Earnings yield.
Prestige Consumer Healthcare Inc. has an earnings yield of 8.50%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings
Overvalued - EBITDA valuation.
Prestige Consumer Healthcare Inc. is overvalued relative to its fair value price of 33.02 based on EBITDA multiple model
Undervalued - EV/EBITDA.
Prestige Consumer Healthcare Inc. has an EV/EBITDA ratio of 9.72x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Overvalued - PEG ratio value.
Prestige Consumer Healthcare Inc. has no meaningful EPS growth rate; PEG ratio cannot be computed.
Undervalued - P/B ratio.
Prestige Consumer Healthcare Inc. has a price-to-book ratio of 1.19x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
Prestige Consumer Healthcare Inc. has a price-to-sales ratio of 2.06x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
12.30%
Return on equity
ROIC: 7.72%
Valuation History
20.0X
Price to Earnings
EV/EBITDA: 14.5X
Cash flow
Profit margin
2.91%
(FY vs FY)
EBITDA Y/Y
0.90%
(FY vs FY)
Cash flow Y/Y
3.57%
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $47.19
5.36%
Default assumptions
EBITDA Multiple
Fair Value
Market $47.19
-30.03%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.